618-07-5Relevant articles and documents
Structural Modification of Aminophenylarsenoxides Generates Candidates for Leukemia Treatment via Thioredoxin Reductase Inhibition
Song, Zi-Long,Zhang, Junmin,Xu, Qianhe,Shi, Danfeng,Yao, Xiaojun,Fang, Jianguo
, p. 16132 - 16146 (2021/11/16)
Upregulation of the selenoprotein thioredoxin reductase (TrxR) is of pathological significance in maintaining tumor phenotypes. Thus, TrxR inhibitors are promising cancer therapeutic agents. We prepared different amino-substituted phenylarsine oxides and evaluated their cytotoxicity and inhibition of TrxR. Compared with our reported p-substituted molecule (8), the o-substituted molecule (10) shows improved efficacy (nearly a fourfold increase) to kill leukemia HL-60 cells. Although the compounds 8 and 10 display similar potency to inhibit the purified TrxR, the o-substitution 10 exhibits higher potency than the p-substitution 8 to inhibit the cellular TrxR activity. Molecular docking results demonstrate the favorable weak interactions of the o-amino group with the TrxR C-terminal active site. Efficient inhibition of TrxR consequently induces the oxidative stress-mediated apoptosis of cancer cells. Silence of the TrxR expression sensitizes the cells to the arsenic compound treatment, further supporting the critical involvement of TrxR in the cellular actions of compound 10.
Organoarsenic compound and use thereof
-
Paragraph 0078; 0080; 0087, (2019/03/06)
The invention discloses an organoarsenic compound. The organoarsenic compound has the following structural formula as shown in the specification, wherein n is 1 or 2; R, R1, R2, R3, R4 and R5 are respectively and independently amino, R6-CO-NH, R7-CO-O, alkyl, aryl, a heterocyclic substituent, alkoxyl, alkylamino, a halogen atom, nitro, hydroxyl or a hydrogen atom; R6 is alkyl, aminoalkyl or aryl;R7 is alkyl, aminoaryl or aryl. The organoarsenic compound has good inhibitory activity for thioredoxin reductase, has strong cytotoxicity for tumor cell HL-60, and can be used for preparing a thioredoxin reductase inhibitor or an antitumor drug with thioredoxin reductase as a target spot.
Substituted phenylarsonic acids; structures and spectroscopy
Lloyd, Nicholas C.,Morgan, Hugh W.,Nicholson, Brian K.,Ronimus, Ron S.
, p. 2443 - 2450 (2008/09/20)
Full NMR and ESI-MS spectra, and differential scanning calorimeter data are presented for 15 substituted phenylarsonic acids, including two new fluoro-substituted examples. X-ray crystal structure determinations of five examples (phenylarsonic acid and the 4-fluoro-, 4-fluoro-3-nitro-, 3-amino-4-hydroxy- and 3-amino-4-methoxy-substituted derivatives) were determined and the H-bonding crystal-packing patterns analysed.
SYNTHESIS AND PROPERTIES OF ARYLARSONIC ACIDS
Yambushev, F. D.,Kovyrzina, V>,P.,Shagidullin, R. R.,Gorchakova, L. A.,Fedotov, B. G.,et al.
, p. 1919 - 1926 (2007/10/02)
1.A number of arylarsonic acids with various substituents in the ortho, meta, and para positions in the benzene ring were synthesized from diazonium salts by the Bart reaction; the products were characterized by their IR spectra. 2.By the DTA method it was established that arylarsonic acid molecules were linked together through hydrogen bonds to form oligomeric associated forms. 3.The IR spectra of arylarsonic acids confirm the presence in them of strong hydrogen bonds through which they are able to undergo association into two forms differing in the symmetry of the d isposition of the As=O bonds.A form which gives a C band arises if the arsonyl oxygen participates in the formation of two hydrogen bonds simultaneously, as a result of which the molecules are linked together to form endless chains and columns.In the other form there are probably cyclic dimers with intermolecular H bonds.